genitalium has yet to be defined, significant associations exist between M. genitalium and cervicitis, pelvic inflammatory disease (PID), and tubal infertility (23,25,30). Among female reproductive tract tissues, M. genitalium DNA has been detected in specimens from the vagina, endocervix, endometrium, and the fallopian tubes, suggesting that, after sexual transmission, the organism can disseminate from the lower to the upper tract. Similarly, outbred mice inoculated vaginally showed time-dependent ascension of M. genitalium from the vagina to the cervix, followed by detection in the uterus, fallopian tubes, and ovaries (27). Therefore, the cervix appears to be either a primary or transient target of infection. Considering the clinical associations of M. genitalium with urogenital inflammation, it remains imperative to investigate the basic mechanisms of mucosal infection and disease induced by this organism.Among male and female reproductive tract syndromes for which M. genitalium has been implicated, all could be attributed to long-term colonization of the urogenital tract, which we refer to here as "persistence." Consistent with the ability to survive longterm in urogenital tissues and similar to other sexually acquired urogenital pathogens, it is hypothesized that M. genitalium has evolved specific mechanisms to evade the host immune system. Indeed, persistent cervical infection has been observed in several clinical studies (4,6,10,13) and has been associated with chronic symptoms (4). Persistent infection by M. genitalium is likely mediated, at least in part, by recombinational variation of genes encoding surface-exposed antigens (13,14,22) and through intracellular localization (2,7,17,26,31). Despite these mechanisms for avoiding the host's immune system, M. genitalium appears to induce a significant inflammatory response, as demonstrated with epidemiologic associations with urogenital disease (25, 30) and the observation that human ecto-and endocervical epithelial cells respond to acute infection with proinflammatory cytokine secretion (26). A link to human immunodeficiency virus (HIV) infection has been observed (29) since cervicitis caused by M. genitalium occurs more often in HIV-positive subjects (20) and, importantly, since M. genitalium persists longer in these women (6). In addition, high M. genitalium burden is correlated with increased HIV shedding from the cervix (24). Collectively, under-
Abstract. Out of 45 cases of fatal chronic pneumonia in calves examined for Mycoplasma bovis infection from February to July 1994, 11 cases with pulmonary abscesses that were culture positive for M. bovis were encountered. The cases were studied in detail using a recently developed monoclonal antibody-based immunoperoxidase technique. Mycoplasma bovis organisms were detected in specific locations at all stages of abscessation observed. In bronchioles or terminal airways within which abscesses developed, M. bovis was located at the epithelial surface and in close association with infiltrating neutrophils and macrophages. Abscessed airways that had lost the epithelium were encapsulated and were seen as coagulative necrotic foci that stained intensely for M. bovis, especially at the periphery. Some foci stained weakly and such might have been resolving lesions. Mycoplasma bovis was also demonstrated at sites of mild mononuclear cell infiltration in the livers and kidneys of 2 calves. The mycoplasma was detected within bile ducts in the liver and in the tubular epithelium of the kidney. Abscesses not staining for M. bovis, presumably caused by other pathogens, were seen concurrently with M. bovis-associated abscesses in some lungs. Thirteen other M. bovis-positive cases showed no abscesses, possibly indicating heterogeneity among M. bovis strains. Three other cases with abscesses were negative for M. bovis by culture and immunoperoxidase staining. The monoclonal antibody-based immunohistochemical technique is efficient for specific detection of M. bovis in cases of enzootic pneumonia of calves with or without abscessation. Mycoplasma bovis is implicated in the pathogenesis of lung abscesses in some calves.Naturally occurring infectious pneumonias of clinical significance usually have complex causes, often requiring the interaction of two or more organisms and predisposing environmental factors.2 Calf pneumonia resistant to antibiotic therapy is frequently encountered in the United States of America and Canada. 10 In areas where calves dying of chronic pneumonia would normally have been treated for bacterial agents, diagnostic effort is necessarily geared towards elucidating the role of viruses and mycoplasmas. Viral agents often cause acute pneumonia in calves, with a histological picture of bronchointerstitial pneumonia. 2Among bovine mycoplasmas recognized in the USA, Canada, and Europe, Mycoplasma bovis stands out as the most invasive and destructive. This mycoplasma can cause pneumonia and arthritis in calves and mastitis in adult cattle .2,7 Mycoplasma bovis has also been cultured from blood.11 There are studies in which M. Received for publication October 7, 1994. bovis was inoculated into calves concurrently with Pasteurella hemolytica, 3 respiratory syncytial virus, 11 and bovine viral diarrhea virus and P. hemolytica. 8 Lesions produced by M. bovis alone were described as focal areas of coagulative necrosis surrounded by mononuclear cells and suppurative bronchiolitis with varying degrees of lympho...
The DNA genome of Mycoplasma genitalium currently represents the smallest of all known human bacterial pathogens. Despite their clinical importance in sexually transmitted infection and relevance as model bacterial pathogens, genomic diversity among M. genitalium strains worldwide is unknown. Herein we present the complete draft genome sequences of four geographically diverse strains of M. genitalium.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.